TriSalus Life Sciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $51.7M | $24.6M | $11.8M |
| FY2024 | $49.9M | $24.0M | $8.5M |
| FY2025 | $69.2M | $35.3M | $20.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $51.7M | $24.6M | $11.8M |
| FY2024 | $49.9M | $24.0M | $8.5M |
| FY2025 | $69.2M | $35.3M | $20.4M |